SCA
DVAX

Snowden Capital Advisors’s Dynavax Technologies DVAX Stock Holding History

Snowden Capital Advisors’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-500
Closed -$7K – 1311
2021
Q4 		$7K Buy
+500
New +$8.23K ﹤0.01% 1600

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

Snowden Capital Advisors's DVAX Position: Q1 2022 in Review

Snowden Capital Advisors sold out of Dynavax Technologies (DVAX) in Q1 2022, closing a stake of 500 shares — an estimated $7K sold.

Snowden Capital Advisors first reported a position in DVAX in Q4 2021 and held it in 1 quarter. The position peaked at $7K in Q4 2021. 207 funds tracked by Wall St. Rank hold DVAX as of Q1 2022.

  • Snowden Capital Advisors reported no remaining Dynavax Technologies position as of Q1 2022 after selling out during the quarter.
  • Snowden Capital Advisors sold 500 Dynavax Technologies shares in Q1 2022, an estimated $7K.
  • Snowden Capital Advisors first reported a position in Dynavax Technologies in Q4 2021 and held it in 1 quarter.
  • Snowden Capital Advisors's Dynavax Technologies position peaked at $7K in Q4 2021.
  • 207 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2022.

Based on Snowden Capital Advisors's 13F filing for Q1 2022, filed 16 May 2022.